Company Description
Broken hearts are hard to mend, but Molecular Insight Pharmaceuticals (MIP) is working to change that. The development-stage company is focused on...
Key Molecular Insight Financials
| Company Type | Public - NASDAQ (GM): MIPI Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $0.7 |
| Employees | -- |
More Molecular Insight Financials (8 pages)
Latest Molecular Insight Jobs jobs by Indeed
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Molecular Insight's competition across multiple industries
Top Molecular Insight Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Molecular Insight Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman and CEO | David S. Barlow | Network | E-mail |
| President, Chief Scientific Officer, and Director | John W. Babich | Network | E-mail |
| COO | John E. McCray | Network | E-mail |
More Molecular Insight Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Molecular Insight News
- Molecular Insight Pharmaceuticals, Inc. (MIPI) Corporate Event Announcement Notice [Wall Street Horizon] (17 Jul 2008 21:27:00 EDT)
- Molecular Insight Pharmaceuticals, Inc. (MIPI) Corporate Event Announcement Notice [Wall Street Horizon] (16 Jul 2008 21:12:00 EDT)